ICD 2025: New data demonstrate Nemluvio’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years

2025年06月20日 14:18:15 来自: (0)参与

An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1
Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3
This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy of Nemluvio in moderate-to-severe prurigo nodularis. The new data show Nemluvio is well tolerated and associated with sustained and clinically meaningful improvements in symptoms including itch and skin lesions, during prolonged treatment up to two years.1 These new data will be presented as a late-breaking session at ICD, on Saturday, June 21, 2025 at 08:30 AM CET.

 

“These promising data go even further in highlighting the extensive benefits of Nemluvio. As this treatment becomes available in more countries around the world, it’s highly encouraging to see its robust evidence base continue to expand and strengthen.”

 

BALDO SCASSELLATI SFORZOLINI, M.D., PHD.

GLOBAL HEAD OF RESEARCH & DEVELOPMENT

GALDERMA

 

 

 
相关新闻
本网网友:血统 FackEdison◎
评论:每天都要做两件事情:晚上不想睡、早上不想起。

百度网友:心不亡wenod∕
评论:现在每天吃的是草,可是挤出来的却是青春痘。

其它网友:别走停下来
评论:人生四项基本原则:懂得选择,学会放弃,耐得住寂寞,经得起诱惑。

腾讯网友:過期愛仍等待
评论:人之所以活得累是因为:放不下架子,撕不开面子,解不开情节。

凤凰网友:错过的情人
评论:我以为你只是颓废,原来你已经报废了。

搜狐网友:厮守°- Michae
评论:你都好意思骗我了,我哪好意思不信。

天猫网友:空心 Vicious▽
评论:再过五十年我就是古董了,所以你趁现在赶紧好好收藏我吧

网易网友:颠覆 wounded
评论:老师说过早恋是不好的,我们很听话,只会暗恋

天涯网友:爱情° love
评论:姐姐曾对我说:妹子你真好看!背面看,想犯罪;侧面看,想到退;正面看,想正当防卫。

淘宝网友:Rainy°伤情
评论:出门顶个避雷针,从此装B再也不怕遭雷劈!

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin